FINWIRES · TerminalLIVE
FINWIRES

B. Riley Initiates Lyell Immunopharma at Buy With $44 Price Target

By

Lyell Immunopharma (LYEL) has an average rating of overweight and mean price target of $38.14, according to analysts polled by FactSet.

What else is happening in Research?